| 1995 |
BIG-2 (CNTN4) was identified as a GPI-anchored cell adhesion molecule with six Ig-like domains and four fibronectin type III-like repeats; recombinant BIG-2 protein promoted neurite outgrowth when used as a substrate for neurons in vitro, establishing its neurite outgrowth-promoting activity. |
Molecular cloning, domain analysis, in vitro neurite outgrowth assay with recombinant protein |
Journal of neurobiology |
High |
8586965
|
| 1997 |
Alternative splicing of BIG-2 (CNTN4) produces a truncated isoform (BIG-2A) lacking the GPI-anchoring domain but retaining six Ig-like domains and a single fibronectin repeat, which is expressed specifically in the vomeronasal and olfactory neuroepithelia. |
cDNA cloning, in situ hybridization |
Brain research. Molecular brain research |
Medium |
9221934
|
| 2002 |
A novel splice variant of human CNTN4 (CNTN4A) encodes a protein with an N-terminal signal peptide, two FNIII-like domains, and a GPI-anchoring domain, and is predominantly expressed in brain. |
cDNA library screening, sequencing, expression analysis |
Journal of human genetics |
Medium |
12202991
|
| 2008 |
BIG-2/CNTN4 functions as an axon guidance molecule required for the convergence of olfactory sensory neuron axons onto correct glomeruli in the olfactory bulb; in BIG-2-deficient mice, neurons expressing a given odorant receptor innervate multiple ectopic glomeruli, disrupting the odor map. |
BIG-2 knockout mouse model, immunohistochemistry, axon tracing, olfactory glomerular mapping |
Neuron |
High |
18367085
|
| 2011 |
Computational steered molecular dynamics analysis of all six IgC2 domains of human CNTN4 revealed that IgC2 domains 2 and 3—critical for interactions with tyrosine phosphatases—are mechanically vulnerable even to weak stretching forces, suggesting tension can modulate CNTN4 binding activity. |
Steered molecular dynamics simulation with CHARMM force field |
Journal of molecular modeling |
Low |
21445711
|
| 2018 |
In Cntn4-/- mice, cell surface levels of glutamate receptor subunits (GluA1, GluA2, GluN1) are reduced in cortex and hippocampus but increased in striatum, and GABAA receptor α1 surface expression is downregulated in multiple brain regions, indicating CNTN4 regulates region-specific glutamate and GABA receptor surface expression. |
Biotinylation assay, western blotting, Cntn4 knockout mouse |
Frontiers in molecular neuroscience |
Medium |
29970989
|
| 2021 |
Cntn4 knockout mice show reduced LTP in hippocampal CA1, abnormal dendritic arborization and spine morphology of CA1 neurons, and enhanced contextual fear conditioning in a gene-dose-dependent manner, establishing CNTN4's role in hippocampal synaptic plasticity and fear memory. |
Cntn4 KO mouse model, electrophysiology (LTP in hippocampal slices), neuroanatomical analysis, behavioral testing (fear conditioning, Morris water maze, novel object recognition) |
Translational psychiatry |
High |
33542194
|
| 2021 |
CNTN4 promotes dendritic spine formation in cortical neurons through a mechanism dependent on its FnIII domains and GPI anchor; truncated proteins lacking the signal peptide, FnIII domains, or GPI domain fail to regulate spine density, and autism-associated variants of CNTN4 lack this ability, leading to reduced excitatory synapses and decreased neural activity. |
Cntn4 disruption in cortical neurons, dendritic spine counting, electrophysiology, domain deletion constructs, autism-variant overexpression |
Human molecular genetics |
High |
34415325
|
| 2022 |
miR-148a-3p directly targets the 3'UTR of CNTN4 (validated by dual-luciferase reporter assay); upregulation of miR-148a-3p suppresses CNTN4 expression and reduces oxLDL-induced macrophage apoptosis and IL-6/TNF-α production. |
Dual-luciferase reporter assay, qRT-PCR, flow cytometry, ELISA in THP-1 macrophages |
Annals of translational medicine |
Medium |
36544657
|
| 2024 |
CNTN4 physically interacts with amyloid precursor protein (APP) as identified by mass spectrometry; knockout of CNTN4 and/or APP in human cells impairs neural elongation, and the CNTN4-APP interaction is required for normal nerve outgrowth, placing CNTN4 upstream of APP in a neurodevelopmental pathway. |
Mass spectrometry proteomics, CNTN4/APP knockout human cells, neural elongation assay |
Open biology |
Medium |
38745463
|